Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Business Update
Medical technology company reports marketing progress of microendoscope for breast cancer
January 26th, 2006
Lifeline Biotechnologies, Inc. (LBTN) announced that the company has reached a number of its important goals for 2005, including continuing its worldwide marketing campaign of MastaScope, a microendoscope that is inserted into a women's breast, permitting the physician to visualize the interior of the milk ducts. The majority of breast cancers originate in the milk ducts. The preliminary market target is women patients who are experiencing nipple discharge. The company introduced the product in China in 2004. Lifeline has recently received a product registration number from the Chinese SDA, which permits Lifeline, through its Shanghai based distributor, to expand its...
Source: Women's Health Weekly (2006-01-26)
|
